Several other analysts have also recently commented on the company. Zacks Investment Research raised IntriCon from a sell rating to a hold rating in a report on Wednesday, July 24th. B. Riley set a $36.00 price target on IntriCon and gave the company a buy rating in a report on Friday, July 19th. Finally, Stifel Nicolaus set a $36.00 price target on IntriCon and gave the company a buy rating in a report on Friday, July 19th. Two investment analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. IntriCon currently has an average rating of Buy and a consensus price target of $38.75.
Shares of IIN traded down $0.26 during mid-day trading on Thursday, hitting $17.83. The company’s stock had a trading volume of 107,517 shares, compared to its average volume of 160,589. The company has a debt-to-equity ratio of 0.04, a current ratio of 3.13 and a quick ratio of 2.23. The business has a 50-day moving average of $21.22. The stock has a market capitalization of $157.09 million, a price-to-earnings ratio of 27.86, a P/E/G ratio of 7.75 and a beta of 0.68. IntriCon has a 1-year low of $16.81 and a 1-year high of $76.80.
IntriCon Corporation, together with its subsidiaries, designs, develops, engineers, manufactures, and distributes body-worn devices in the United States, Europe, Asia, and internationally. The company operates in two segments, Body Worn Devices and Hearing Health Direct-To-Consumer. It offers micro-miniature products, microelectronics; micro-mechanical assemblies; high-precision injection-molded plastic components; and assemblies and software solutions for medical biotelemetry devices, hearing healthcare, and professional audio communication devices markets.
Recommended Story: What is a Reverse Stock Split?
To view ValuEngine’s full report, visit ValuEngine’s official website.
Receive News & Ratings for IntriCon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IntriCon and related companies with MarketBeat.com's FREE daily email newsletter.